Bottom line
What is HBIOX's expense ratio?
HBIOX's expense ratio is 1.01%, or about $101 a year on every $10,000 invested. That is more expensive than 61% of international stock funds we track (median 0.9%). Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Apr 14, 2026
HBIOX fee table
| Net expense ratio | 1.01% |
|---|---|
| Gross expense ratio | 1.01% |
| Management fee | 0.72% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.04% |
Source: Fund prospectus fee table, filed Apr 14, 2026
What HBIOX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| HBIOX | $103 | $322 | $558 | $1,236 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.01% expense ratio costs roughly $55,900 in lost growth, versus about $50,300 for the median international stock fund (0.9%).
Cheaper alternatives to HBIOX
These funds have a similar portfolio (by top-holdings overlap) and a lower expense ratio. Savings are per $10,000 invested.
| Fund | Expense ratio | Saves per year | Saves over 20 yrs* | Overlap |
|---|---|---|---|---|
| FSGGX Fidelity | 0.055% | $96 | $5,258 | 50% |
*Difference in ending value of $10,000 after 20 years at a 6% gross annual return, net of each fund's expense ratio.